Kullanım Kılavuzu
Neden sadece 3 sonuç görüntüleyebiliyorum?
Sadece üye olan kurumların ağından bağlandığınız da tüm sonuçları görüntüleyebilirsiniz. Üye olmayan kurumlar için kurum yetkililerinin başvurması durumunda 1 aylık ücretsiz deneme sürümü açmaktayız.
Benim olmayan çok sonuç geliyor?
Birçok kaynakça da atıflar "Soyad, İ" olarak gösterildiği için özellikle Soyad ve isminin baş harfi aynı olan akademisyenlerin atıfları zaman zaman karışabilmektedir. Bu sorun tüm dünyadaki atıf dizinlerinin sıkça karşılaştığı bir sorundur.
Sadece ilgili makaleme yapılan atıfları nasıl görebilirim?
Makalenizin ismini arattıktan sonra detaylar kısmına bastığınız anda seçtiğiniz makaleye yapılan atıfları görebilirsiniz.
 ASOS INDEKS
 Görüntüleme 6
Role of non-invasive ventilation (NIV) for treatment of acute respiratory failure (ARF) among patients with non cystic fibrosis (CF) bronchiectasis
2021
Dergi:  
International Journal of Health and Clinical Research
Yazar:  
Özet:

Aim: The aim of this study to evaluate the role of non-invasive ventilation (NIV) for treatment of acute respiratory failure (ARF) among patients with non cystic fibrosis (CF) bronchiectasis. Material and methods: This was a retrospective study conducted in the Department of Anaesthesiology, Jawaharlal Nehru medical college and hospital Bhagalpur, Bihar, India from May 2018 to February 2019. We included 100 patients with bronchiectasis and ARF who required either NIV or invasive mechanical ventilation (IMV). Results:  There was a total of 200 patients with bronchiectasis, Among these, 100 patients were admitted with ARF. Totally 100 patients who required either NIV or IMV. The most common etiology of bronchiectasis was post‑tuberculosis (50%) followed by idiopathic (20%), ABPA (15%), and immunodeficiency (5%). NIV was initiated as first line of ventilator support for 80 patients. Among these, 51(63.75%) were managed successfully with NIV. 29 (36.25%) patients failed NIV and required endotracheal intubation during the hospital stay. Reasons for NIV failure were worsening or non-improvement of ventilatory or oxygenation parameters (n=14), hypotension (n=6), worsening of sensorium (n=4), and intolerance (n=5). NIV failure occurred after a median duration of 2.77(95% confidence interval [CI] 1.51–4.24) days after the initiation. There were total 11 deaths in the study group. Among patients who failed NIV, total days (median [range]) spent on ventilator (6.6 [2–62] vs. 6.1 [3–16] days; P=0.41), duration (median [range]) of hospital stay (8 [4–64] vs. 11 [5–15] days; P=0.27), and mortality (8 [10%] vs 3 [15%]; P=0.24) were comparable to the IMV group. The causes of death among patients who failed NIV were septic shock (n=5) and ventilator-associated pneumonia (n=3). Conclusions: NIV is feasible for management of ARF with non-CF bronchiectasis. High APACHE may predict NIV failure among these patients. Keywords: Acute respiratory failure, mechanical ventilation, noncystic fibrosis bronchiectasis, noninvasive ventilation.

Anahtar Kelimeler:

Atıf Yapanlar
Bilgi: Bu yayına herhangi bir atıf yapılmamıştır.
Benzer Makaleler








International Journal of Health and Clinical Research

Dergi Türü :   Uluslararası

International Journal of Health and Clinical Research